APA (7th ed.) Citation

A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, & D. R. Naskhletashvili. (2018). Pharmacoeconomic analysis of trastuzumab emtanzine comparing to lapatinib + capecitabine in pa-tients with HER2+ breast cancer and central nervous system metastases. Izdatelstvo OKI.

Chicago Style (17th ed.) Citation

A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, and D. R. Naskhletashvili. Pharmacoeconomic Analysis of Trastuzumab Emtanzine Comparing to Lapatinib + Capecitabine in Pa-tients with HER2+ Breast Cancer and Central Nervous System Metastases. Izdatelstvo OKI, 2018.

MLA (9th ed.) Citation

A. S. Kolbin, et al. Pharmacoeconomic Analysis of Trastuzumab Emtanzine Comparing to Lapatinib + Capecitabine in Pa-tients with HER2+ Breast Cancer and Central Nervous System Metastases. Izdatelstvo OKI, 2018.